Tempus partners with Whitehawk Therapeutics for cancer research
Go back to Tempus partners with Whitehawk Therapeutics for cancer research| StemCells, Inc. (NASDAQ: TEM) | Delayed: 49.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.36 | 52 Week High | $0.45 | |||
| Open | $49.36 | 52 Week Low | $0.37 | |||
| Day High | $49.36 | P/E | N/A | |||
| Day Low | $49.36 | EPS | $-0.31 | |||
| Volume | 957,171 | |||||
| (NASDAQ: WHWK) | Delayed: 4.76 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.76 | 52 Week High | $ | |||
| Open | $4.76 | 52 Week Low | $ | |||
| Day High | $4.76 | P/E | N/A | |||
| Day Low | $4.76 | EPS | $ | |||
| Volume | 639 | |||||

